Trotta F - Search Results

1

Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles.

Clemente N, Boggio E, Gigliotti LC, Raineri D, Ferrara B, Miglio G, Argenziano M, Chiocchetti A, Cappellano G, Trotta F, Caldera F, Capucchio MT, Yagi J, Rojo MJ, Renò F, Cavalli R, Dianzani C, Dianzani U. Clemente N, et al. Among authors: trotta f. J Control Release. 2020 Apr 10;320:112-124. doi: 10.1016/j.jconrel.2020.01.030. Epub 2020 Jan 18. J Control Release. 2020. PMID: 31962094

2

Effect of alkylcarbonates of gamma-cyclodextrins with different chain lengths on drug complexation and release characteristics.

Cavalli R, Trotta F, Trotta M, Pastero L, Aquilano D. Cavalli R, et al. Among authors: trotta f, trotta m. Int J Pharm. 2007 Jul 18;339(1-2):197-204. doi: 10.1016/j.ijpharm.2007.03.001. Epub 2007 Mar 12. Int J Pharm. 2007. PMID: 17418510

3

Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/poly(amidoamine) copolymer.

Bencini M, Ranucci E, Ferruti P, Trotta F, Donalisio M, Cornaglia M, Lembo D, Cavalli R. Bencini M, et al. Among authors: trotta f. J Control Release. 2008 Feb 18;126(1):17-25. doi: 10.1016/j.jconrel.2007.11.004. Epub 2007 Nov 17. J Control Release. 2008. PMID: 18079013

4

Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.

Cavalli R, Donalisio M, Civra A, Ferruti P, Ranucci E, Trotta F, Lembo D. Cavalli R, et al. Among authors: trotta f. J Control Release. 2009 Jul 20;137(2):116-22. doi: 10.1016/j.jconrel.2009.04.004. Epub 2009 Apr 8. J Control Release. 2009. PMID: 19361545

5

Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity.

Swaminathan S, Pastero L, Serpe L, Trotta F, Vavia P, Aquilano D, Trotta M, Zara G, Cavalli R. Swaminathan S, et al. Among authors: trotta f, trotta m. Eur J Pharm Biopharm. 2010 Feb;74(2):193-201. doi: 10.1016/j.ejpb.2009.11.003. Epub 2009 Nov 10. Eur J Pharm Biopharm. 2010. PMID: 19900544

6

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges.

Torne SJ, Ansari KA, Vavia PR, Trotta F, Cavalli R. Torne SJ, et al. Among authors: trotta f. Drug Deliv. 2010 Aug;17(6):419-25. doi: 10.3109/10717541003777233. Drug Deliv. 2010. PMID: 20429848

7

Nanosponge formulations as oxygen delivery systems.

Cavalli R, Akhter AK, Bisazza A, Giustetto P, Trotta F, Vavia P. Cavalli R, et al. Among authors: trotta f. Int J Pharm. 2010 Dec 15;402(1-2):254-7. doi: 10.1016/j.ijpharm.2010.09.025. Epub 2010 Oct 1. Int J Pharm. 2010. PMID: 20888402

8

Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.

Ansari KA, Vavia PR, Trotta F, Cavalli R. Ansari KA, et al. Among authors: trotta f. AAPS PharmSciTech. 2011 Mar;12(1):279-86. doi: 10.1208/s12249-011-9584-3. Epub 2011 Jan 15. AAPS PharmSciTech. 2011. PMID: 21240574 Free PMC article.

9

Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.

Minelli R, Cavalli R, Ellis L, Pettazzoni P, Trotta F, Ciamporcero E, Barrera G, Fantozzi R, Dianzani C, Pili R. Minelli R, et al. Among authors: trotta f. Eur J Pharm Sci. 2012 Nov 20;47(4):686-94. doi: 10.1016/j.ejps.2012.08.003. Epub 2012 Aug 15. Eur J Pharm Sci. 2012. PMID: 22917641 Free article.

10

Cyclodextrin-based nanosponges as drug carriers.

Trotta F, Zanetti M, Cavalli R. Trotta F, et al. Beilstein J Org Chem. 2012;8:2091-9. doi: 10.3762/bjoc.8.235. Epub 2012 Nov 29. Beilstein J Org Chem. 2012. PMID: 23243470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

557 results

Search Page